Renal Treatment Centers - Southeast LP

Renal Treatment Centers - Southeast LP, doing business as Amarillo East Acutes, is a subsidiary of DaVita Inc. that operates as a federal prime contractor delivering on-site inpatient and peritoneal hemodialysis services to veterans at the Amarillo VA Health Care System in Amarillo, Texas. The vendor competes in full-and-open procurements with no set-aside designations across its entire federal footprint.

The vendor operates under a single-award indefinite-delivery contract (IDC VA25816D0003) valued at $966,662 through April 12, 2027, issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 (VISN 17) in April 2022. Under this IDC, the vendor has received nine task orders since award, with the most recent delivery order (Exercise Option Year Four) issued on April 13, 2026, for $204,928 and extending through the contract's completion date. Prior task orders include Option Year Three ($198,980, April 2025), Option Year Two ($131,239, April 2024), Option Year One ($120,040, April 2023), and the base year ($95,332, April 2022). All delivery orders are structured as firm fixed-price awards requiring 24/7 on-site hemodialysis and peritoneal dialysis treatment services to veterans. As of the most recent award, $732,479 in total obligations have been executed against the IDC. The vendor also holds position on a second IDC (36C25722D0044) under which five additional task orders have been issued, carrying $751,000 in combined potential value.

Customer concentration is absolute: all sixteen awards across the vendor's federal footprint originate from VA VISN 17, representing 100% of recent prime work and $3.1 million in combined potential value. Activity volume remains minimal and flat — one award per year from 2023 through 2026 — with only one award (the current April 2026 delivery order valued at $205,000) reaching completion within the next twenty-four months. Combined obligated dollars across all awards total $1.2 million against $3.1 million in combined potential value, representing a 39% obligation rate. The vendor operates exclusively as a prime contractor with no subcontract engagements in the federal space; its parent company, DaVita Inc., anchors broader VA dialysis services delivery across multiple regional service networks and a $1.197 billion national dialysis contract vehicle with VA Headquarters.